ArticleInternational journal of nanomedicine2019

Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy.

Nayab Tahir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.